Global Organ Transplantation Demand Will Expand Market Opportunity

AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Published
02 Apr 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
SEK 75.50
59.8% undervalued intrinsic discount
08 Aug
SEK 30.38
Loading
1Y
-21.9%
7D
6.7%

Author's Valuation

SEK 75.5

59.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 26%

Shared on24 Apr 25
Fair value Decreased 43%

AnalystConsensusTarget has increased revenue growth from 90.1% to 99.4%, decreased profit margin from 16.7% to 12.0% and increased future PE multiple from 49.8x to 60.1x.

Shared on17 Apr 25
Fair value Increased 15%

AnalystConsensusTarget has increased revenue growth from 80.3% to 90.1%.

Shared on09 Apr 25
Fair value Increased 12%

AnalystConsensusTarget has decreased revenue growth from 91.8% to 80.3% and increased future PE multiple from 37.2x to 50.5x.